All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Dec. 18, 2025 (HealthDay News) — A new rapid test could improve treatment of ...

Researchers at the Technical University of Munich (TUM) have developed a method for diagnosing urinary tract infections that ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...

Cystitis and urinary tract infections can be a recurrent problem for many people. The pathogenic bacteria that can cause these bladder infections are also becoming increasingly resistant to ...

Blujepa (gepotidacin) is a new antibiotic recently approved by the FDA for treating bladder infections caused by certain bacteria in women and girls ages 12 and older. Blujepa works differently than ...

Dr. Lacy Anderson explains how to prevent recurrent UTIs, noting causes, risk factors, and treatments, including lifestyle ...

NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Biotia today announced the launch of a new "test to treat" option for patients suffering from recurrent urinary tract infections (UTIs), moving UTI care forward ...

Diagnosing a UTI involves examining a urine sample to detect the presence of bacteria or using imaging tests to diagnose other underlying causes. Usually, experiencing symptoms prompts a doctor to ...

If you're among the millions of women suffering from interstitial cystitis, a bladder disorder characterized by intense discomfort, you may have struggled for years to find the right treatment. For ...

Urinary tract infections are common, and the risk generally increases with age. They happen when bacteria infect your urethra, bladder, or other organs in your urinary tract. In older people, UTIs ...